5. Beck A, Goetsch L, Dumontet C, Corva?a N, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
6. Diamantis N, Banerji U, et al. Antibody-drug conjugates--an emerging class of cancer treatment. Br J Cancer. 2016 Feb 16;114(4):362-7.
7. Drago JZ, Modi S, Chandarlapaty S, et al. Unlocking the potential of antibody-drug conjugates for cancer therapy. Nat Rev Clin Oncol. 2021 Jun;18(6):327-344.
8. Nakada T, Sugihara K, Jikoh T, Abe Y, Agatsuma T, et al. The Latest Research and Development into the Antibody-Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy. Chem Pharm Bull (Tokyo). 2019;67(3):173-185.
9. Tsuchikama K, An Z, et al. Antibody-drug conjugates: recent advances in conjugation and linker chemistries. Protein Cell. 2018 Jan;9(1):33-46
推荐阅读
- 区块|面向2030:影响数据存储产业的十大应用(下):新兴应用
- 转向|时代落幕,佳能:1DX3 将会是旗下最后一款旗舰单反
- 集聚|向全球应用创新策源地持续迈进 上海“双千兆”应用体验中心正式揭牌
- 警告!|华为联想卷入滴滴高管千万受贿案 判决书曝光浪潮曾向其输送720多万
- 何由|2021年,奔向星辰大海的脚步更稳更远!
- 风湿|钟南山邀张桂梅赴广州治疗
- 西湖|施一公:创新,永远向顶尖发力!
- Hotel|向光前行,点亮未来 -- 2022上海国际商业及工程照明展
- 智能汽车|瞄准2022的靶心 智能汽车还要深挖潜力
- 趋势|[转]从“智能湖仓”升级看数据平台架构未来方向